← Back to Search

Standard Automatic Perimetry Humphrey Field Analyzer for Open-Angle Glaucoma

N/A
Waitlist Available
Led By M Reza Razeghinejad, MD
Research Sponsored by Wills Eye
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three hours
Awards & highlights

Summary

To determine age-adjusted reference values of the visuALL Field Analyzer (vFA) retinal sensitivity and to assess the repeatability of the measured values and compare them with those measured by a Standard Automatic Perimetry (SAP).

Eligible Conditions
  • Open-Angle Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and three hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Global Correlation (Agreement Between Two Machines in the Overall Visual Field)
Mean Retinal Sensitivity From Two Machines
Secondary outcome measures
Inferior Nasal Quadrant Correlation (Agreement Between Two Machines in the Inferior Nasal Visual Field)
Superior Hemifield Correlation (Agreement Between Two Machines in the Superior Hemifield Visual Field

Trial Design

2Treatment groups
Experimental Treatment
Group I: Mild and Moderate GlaucomaExperimental Treatment2 Interventions
Subjects between 21 and 80 years of age with Mild or Moderate Glaucoma. Eyes will have a reliable standard automatic perimetry with no more than -6 mean deviation (Mild) and between -6 mean and -12 mean deviation (Moderate). Spherical refraction will be less than 3 diopters and cylinder correction equal to 2 diopters or less. All subjects will perform Standard Automatic Perimetry Humphrey Field Analyzer and visuALL Field Analyzer to measure peripheral and central visual field.
Group II: Healthy ControlsExperimental Treatment2 Interventions
Healthy subjects between 21 and 80 years of age with no eye diseases (normal appearing optic nerve and retina, intraocular eye pressure less than 19 millimeters of mercury, normal and reliable standard automatic perimetry, and spherical refraction less than 3 diopters and cylinder correction equal to 2 diopters or less. All subjects will perform Standard Automatic Perimetry Humphrey Field Analyzer and visuALL Field Analyzer to measure peripheral and central visual field.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
visuALL Field Analyzer
2019
N/A
~80
Standard Automatic Perimetry Humphrey Field Analyzer
2019
N/A
~80

Find a Location

Who is running the clinical trial?

Wills EyeLead Sponsor
80 Previous Clinical Trials
15,364 Total Patients Enrolled
Olleyes, Inc.UNKNOWN
M Reza Razeghinejad, MDPrincipal InvestigatorWills Eye
~11 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top